8-K
Current Report
4D Molecular Therapeutics, Inc. Filed Acc 0001193125-26-131739
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading fdmt-20260325.htm…